Ada Cuellar, MD | |
2101 Pease St, Harlingen, TX 78550-8307 | |
(956) 389-1100 | |
Not Available |
Full Name | Ada Cuellar |
---|---|
Gender | Female |
Speciality | Emergency Medicine |
Location | 2101 Pease St, Harlingen, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467613414 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | N1598 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ada Cuellar, MD 2101 Pease St, Harlingen, TX 78550-8307 Ph: () - | Ada Cuellar, MD 2101 Pease St, Harlingen, TX 78550-8307 Ph: (956) 389-1100 |
News Archive
Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXAâ„¢ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Millions of patients will benefit from earlier diagnostic tests closer to home thanks to 40 new Community Diagnostic Centres set to open across England in a range of settings from local shopping centers to football stadiums.
Scientists have found that genetic variations for an enzyme involved in cell energy metabolism may increase the risk of prostate cancer. This variation in genes may impair the enzyme phosphodiesterase 11A (PDE11A), which helps regulate cells' responses to hormones and other signals, according to the U.S. National Institute of Child Health and Human Development researchers and colleagues.
Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME).
A new report has found a gaping $250 billion hole in what New York state and local governments have promised to public employees to help pay for their retiree health care costs - a $45 billion increase since 2010.
› Verified 7 days ago
Julie D Sorenson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2106 Treasure Hills Blvd, Harlingen, TX 78550 Phone: 956-366-4500 Fax: 956-366-4501 | |
Dr. Phillip M. Grandstaff, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 210 Richmond Ct, Harlingen, TX 78552 Phone: 956-230-0896 | |
Ismael Garcia Jr., MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2937 Jacaranda Dr, Harlingen, TX 78550 Phone: 956-345-9950 | |
Robert T Wright, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 | |
Michael T Mohun Jr., MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 | |
James Young, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 | |
Dr. Kyle Beasley, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2101 Pease St, Harlingen, TX 78550 Phone: 956-389-1100 |